EPIRUBICIN Safety Questions, EPIRUBICIN Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about EPIRUBICIN. Our extensive database of EPIRUBICIN adverse events and EPIRUBICIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about EPIRUBICIN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet



EPIRUBICIN Safety Reports

Total EPIRUBICIN reports: 130.
EPIRUBICIN FDA safety alerts: 2007 .
Reported deaths: 34    Reported hospitalizations: 58.
Take EPIRUBICIN Side Effects Survey or Share Your EPIRUBICIN Story. Read More Here.

Showing 1-75 of 130 Next >

Health Professional from UNITED KINGDOM reported EPIRUBICIN problem on Sept 25, 2006. Female patient, 64 years of age, weighting 125.4 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, neutrophil count decreased. EPIRUBICIN dosage: 140 MG TOTAL IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADCAL, ZOMETA. Patient died on 08/21/2006.

EPIRUBICIN problem was reported by a Health Professional from UNITED KINGDOM on Sept 22, 2006. Female patient, 70 years of age, was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: angina pectoris, chest pain. EPIRUBICIN dosage: unknown. During the same period patient was treated with CARBOPLATIN, ASPIRIN, BENDROFLUMETHIAZIDE, FELODIPINE, LACTULOSE. Patient was hospitalized. Patient recovered.

Physician from reported EPIRUBICIN problem on Oct 11, 2006. Female patient, 60 years of age, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: chills, leukopenia, mental disorder, pyrexia, restlessness, tachycardia. EPIRUBICIN dosage: (294 MG, 2 IN 1 WK), INTRAVENOUS. During the same period patient was treated with TAXOL, CYCLOPHOSPHAMIDE, ARANESP, NEULASTA, PLASTULEN N, FORTECORTIN, ZOFRAN, EMEND. Patient was hospitalized. Patient recovered.

EPIRUBICIN problem was reported by a Health Professional from FRANCE on Oct 09, 2006. Female patient, 42 years of age, weighting 105.8 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: cholestasis, cytolytic hepatitis, pain. EPIRUBICIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported EPIRUBICIN problem on Oct 12, 2006. Male patient, 77 years of age, was diagnosed with hepatic neoplasm malignant and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: alveolitis allergic, pleural effusion, pneumonia, procedural complication, vascular anomaly. EPIRUBICIN dosage: 30 MG (1 IN 1 D), INTRA-ARTERIAL. During the same period patient was treated with LIPIODOL ULTRA, DEXTROMETHORPHAN HYDROBROMIDE, MUCODYNE, USRO, LEVOTHYROXINE, BLOPRESS, BASEN, NIKORANMART. Patient was hospitalized. Patient recovered.

EPIRUBICIN problem was reported by a Health Professional from UNITED KINGDOM on Oct 17, 2006. Female patient, 59 years of age, weighting 187.4 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: phlebosclerosis. EPIRUBICIN dosage: unknown. During the same period patient was treated with OMEPRAZOLE, METFORMIN, LIPITOR, ASPIRIN. Patient recovered.

Physician from JAPAN reported EPIRUBICIN problem on Oct 25, 2006. Male patient was diagnosed with hepatic neoplasm and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: hepatic neoplasm malignant recurrent, metastases to bone, metastases to lymph nodes, neuroendocrine carcinoma. EPIRUBICIN dosage: unknown. Patient died on 09/01/2005.

EPIRUBICIN problem was reported by a Physician from JAPAN on Nov 09, 2006. Female patient, 65 years of age, weighting 132.3 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, lymphocyte stimulation test positive. EPIRUBICIN dosage: 110 MG (110 MG, 1 IN 1 D). During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE, PAXIL, DEPROMEL, FLUMEZIN, ARTANE, LORAZEPAM, ARICEPT. Patient was hospitalized and became disabled. Patient recovered.

Physician from GERMANY reported EPIRUBICIN problem on Nov 08, 2006. Female patient, 65 years of age, weighting 242.5 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: erythema, extravasation, impaired healing, infection, necrosis. EPIRUBICIN dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

EPIRUBICIN problem was reported by a Physician from UNITED KINGDOM on Nov 14, 2006. Female patient, 60 years of age, weighting 224.9 lb, was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: bedridden, headache, photopsia. EPIRUBICIN dosage: (200 MG, 1 IN 1 D), INTRAVENOUS. During the same period patient was treated with NEULASTA, SALBUTAMOL, ONDANSETRON. Patient recovered.

Physician from FRANCE reported EPIRUBICIN problem on Nov 23, 2006. Female patient, 60 years of age, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: angiopathy, erythema, petechiae. EPIRUBICIN dosage: 100 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL. Patient recovered.

EPIRUBICIN problem was reported by a Physician from JAPAN on Nov 20, 2006. Female patient, 59 years of age, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, interstitial lung disease, vasculitis, white blood cell count decreased. EPIRUBICIN dosage: 25 MG MG/M*2 (WEEKLY). During the same period patient was treated with DOCETAXEL. Patient recovered.

Pharmacist from JAPAN reported EPIRUBICIN problem on Nov 28, 2006. Female patient, 60 years of age, was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. EPIRUBICIN dosage: 100MG/M. During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE. Patient recovered.

EPIRUBICIN problem was reported by a Physician from JAPAN on Dec 06, 2006. Female patient, 60 years of age, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. EPIRUBICIN dosage: 100 MG/M*2, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE. Patient recovered.

Health Professional from UNITED KINGDOM reported EPIRUBICIN problem on Dec 15, 2006. Female patient, 47 years of age, weighting 206.8 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: erythema, pain in extremity, tenderness. EPIRUBICIN dosage: unknown. Patient recovered.

EPIRUBICIN problem was reported by a Health Professional from UNITED KINGDOM on Dec 15, 2006. Female patient, 41 years of age, weighting 154.3 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: dyskinesia, pain in extremity. EPIRUBICIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported EPIRUBICIN problem on Dec 08, 2006. Female patient, 47 years of age, weighting 206.8 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: erythema, pain in extremity. EPIRUBICIN dosage: 200 MG Q3W IV. Patient recovered.

EPIRUBICIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 08, 2006. Female patient, 35 years of age, weighting 215.2 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: limb discomfort. EPIRUBICIN dosage: 200 MG 3/WK IV. During the same period patient was treated with LEVOTHYROXINE. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported EPIRUBICIN problem on Dec 08, 2006. Female patient, 41 years of age, weighting 154.3 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: injected limb mobility decreased, pain in extremity. EPIRUBICIN dosage: 180 MG PER_CYCLE IV. Patient recovered.

EPIRUBICIN problem was reported by a Physician from FRANCE on Nov 23, 2006. Female patient, weighting 172.0 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: erythema, petechiae. EPIRUBICIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL. Patient recovered.

Pharmacist from JAPAN reported EPIRUBICIN problem on Dec 08, 2006. Female patient was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: vasculitis. EPIRUBICIN dosage: DAILY DOSE:100MG/M*2. During the same period patient was treated with DECADRON, FLUOROURACIL, CYCLOPHOSPHAMIDE. Patient recovered.

EPIRUBICIN problem was reported by a Physician from JAPAN on Dec 08, 2006. Female patient was diagnosed with hepatitis c and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: anti-platelet antibody positive, embolism, platelet count decreased. EPIRUBICIN dosage: unknown. During the same period patient was treated with LIPIODOL ULTRA. Patient died.

Health Professional from UNITED KINGDOM reported EPIRUBICIN problem on Dec 15, 2006. Female patient, 36 years of age, weighting 180.8 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: injection site pain, malaise, pain in extremity. EPIRUBICIN dosage: unknown. Patient recovered.

EPIRUBICIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 21, 2007. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: blood culture positive, candida serology positive, febrile neutropenia, fungus sputum test positive, pneumonitis, respiratory failure, streptococcal infection. EPIRUBICIN dosage: unknown. During the same period patient was treated with CARBOPLATIN, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE. Patient died.

Pharmacist from JAPAN reported EPIRUBICIN problem on June 22, 2007. Female patient, 40 years of age, was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: angiopathy, pigmentation disorder, vasculitis. EPIRUBICIN dosage: DAILY DOSE:100MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL. Patient recovered.

EPIRUBICIN problem was reported by a Pharmacist from JAPAN on June 27, 2007. Female patient, 66 years of age, was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: angiopathy, phlebitis, pigmentation disorder. EPIRUBICIN dosage: DAILY DOSE:100MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL. Patient recovered.

Health Professional from GREECE reported EPIRUBICIN problem on June 29, 2007. Male patient, 65 years of age, weighting 143.3 lb, was diagnosed with bladder cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: cystitis interstitial. EPIRUBICIN dosage: unknown. Patient recovered.

EPIRUBICIN problem was reported by a Health Professional from UNITED KINGDOM on July 06, 2007. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. EPIRUBICIN dosage: unknown. During the same period patient was treated with CARBOPLATIN, VINCRISTINE, ETOPOSIDE, IFOSFAMIDE, ACTINOMYCIN D. Patient died.

Health Professional from GERMANY reported EPIRUBICIN problem on July 17, 2007. Female patient, 45 years of age, weighting 165.3 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: oesophagitis. EPIRUBICIN dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

EPIRUBICIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 12, 2007. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: pneumonitis. EPIRUBICIN dosage: unknown. During the same period patient was treated with CARBOPLATIN, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE. Patient was hospitalized. Patient died.

Consumer or non-health professional from SPAIN reported EPIRUBICIN problem on July 19, 2007. Male patient, weighting 158.7 lb, was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: asthenia, neutropenia. EPIRUBICIN dosage: unknown. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, HIPOARTEL. Patient was hospitalized. Patient recovered.

EPIRUBICIN problem was reported by a Consumer or non-health professional from ITALY on July 24, 2007. Female patient, 50 years of age, was diagnosed with breast cancer and was treated with EPIRUBICIN. EPIRUBICIN dosage: DAILY DOSE:75MG/M*2. During the same period patient was treated with DOCETAXEL, NEUPOGEN. Patient died on 07/15/2007.

Consumer or non-health professional from UNITED KINGDOM reported EPIRUBICIN problem on July 20, 2007. Male patient was diagnosed with rhabdomyosarcoma and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, interstitial lung disease, ototoxicity, recall phenomenon, respiratory failure. EPIRUBICIN dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient was hospitalized. Patient died.

EPIRUBICIN problem was reported by a Health Professional from GREECE on July 24, 2007. Male patient, 65 years of age, weighting 143.3 lb, was diagnosed with bladder cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: cystitis interstitial. EPIRUBICIN dosage: unknown. Patient recovered.

Consumer or non-health professional from ITALY reported EPIRUBICIN problem on July 24, 2007. Female patient, 50 years of age, was diagnosed with breast cancer and was treated with EPIRUBICIN. EPIRUBICIN dosage: DAILY DOSE:75MG/M*2. During the same period patient was treated with DOCETAXEL, NEUPOGEN. Patient died on 07/15/2007.

EPIRUBICIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 24, 2007. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: beta haemolytic streptococcal infection, blood culture positive, candidiasis, febrile neutropenia, mucosal inflammation, pneumonitis. EPIRUBICIN dosage: unknown. During the same period patient was treated with CARBOPLATIN, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE. Patient was hospitalized. Patient died.

Health Professional from UNITED STATES reported EPIRUBICIN problem on July 26, 2007. Male patient, 74 years of age, was diagnosed with oesophageal adenocarcinoma and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: anaemia, bone marrow failure, rash pruritic, thrombocytopenia, white blood cell count decreased. EPIRUBICIN dosage: unknown. During the same period patient was treated with METHOTREXATE, MITOMYCIN, ETOPOSIDE, FLUOROURACIL, PROLEUKIN, LEUCOVORIN CALCIUM. Patient recovered.

EPIRUBICIN problem was reported by a Health Professional from UNITED STATES on Aug 07, 2007. Female patient, 38 years of age, weighting 149.0 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, jugular vein thrombosis. EPIRUBICIN dosage: 149MG Q3WK IV BOLUS. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported EPIRUBICIN problem on Aug 01, 2007. Female patient, 59 years of age, was diagnosed with bladder cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: anorexia, fatigue, hepatitis b. EPIRUBICIN dosage: unknown. During the same period patient was treated with CISPLATIN, METHOTREXATE. Patient recovered.

EPIRUBICIN problem was reported by a Physician from JAPAN on Aug 03, 2007. Male patient, weighting 169.8 lb, was diagnosed with bladder neoplasm and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: toxic skin eruption. EPIRUBICIN dosage: unknown. During the same period patient was treated with PANSPORIN, ADONA, TRANSAMIN. Patient recovered.

Consumer or non-health professional from JAPAN reported EPIRUBICIN problem on Aug 09, 2007. Female patient, 59 years of age, was diagnosed with bladder cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: anorexia, fatigue, hepatitis b. EPIRUBICIN dosage: unknown. During the same period patient was treated with CISPLATIN, METHOTREXATE, DEXAMETHASONE. Patient recovered.

EPIRUBICIN problem was reported by a Health Professional from FRANCE on Aug 07, 2007. Female patient was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, neoplasm malignant. EPIRUBICIN dosage: DAILY DOSE:85MG-FREQ:CYCLIC. During the same period patient was treated with FLUOROURACIL, ENDOXAN, TAMOXIFEN CITRATE. Patient was hospitalized. Patient recovered.

Physician from FINLAND reported EPIRUBICIN problem on Aug 06, 2007. Female patient, 35 years of age, was diagnosed with malignant histiocytosis and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: acute promyelocytic leukaemia. EPIRUBICIN dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient died.

EPIRUBICIN problem was reported by a Physician from JAPAN on Aug 09, 2007. Female patient, weighting 97.00 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, sepsis. EPIRUBICIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, ENDOXAN. Patient was hospitalized. Patient died on 07/25/2007.

Consumer or non-health professional from NETHERLANDS reported EPIRUBICIN problem on Aug 13, 2007. Female patient, weighting 136.7 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: breast cancer. EPIRUBICIN dosage: unknown. During the same period patient was treated with DOCETAXEL, TAMOXIFEN CITRATE. Patient recovered.

EPIRUBICIN problem was reported by a Health Professional from UNITED STATES on Aug 24, 2007. Female patient, 58 years of age, weighting 130.0 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: asthma, chronic obstructive pulmonary disease, dyspnoea, neutropenia. EPIRUBICIN dosage: 90 MG/M2 Q3WK X 4 IV BOLUS. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported EPIRUBICIN problem on Aug 21, 2007. Female patient, weighting 97.00 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, neutropenia, sepsis. EPIRUBICIN dosage: unknown. During the same period patient was treated with ENDOXAN. Patient was hospitalized. Patient died on 07/25/2007.

EPIRUBICIN problem was reported by a Physician from JAPAN on Aug 23, 2007. Male patient, weighting 169.8 lb, was diagnosed with bladder neoplasm and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: toxic skin eruption. EPIRUBICIN dosage: unknown. During the same period patient was treated with PANSPORIN, ADONA, TRANSAMIN. Patient recovered.

Consumer or non-health professional from NETHERLANDS reported EPIRUBICIN problem on Aug 24, 2007. Female patient, weighting 136.7 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: breast cancer. EPIRUBICIN dosage: DAILY DOSE:80MG. During the same period patient was treated with DOCETAXEL, TAMOXIFEN CITRATE. Patient recovered.

EPIRUBICIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 29, 2007. Female patient, weighting 191.8 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, dysphasia, odynophagia. EPIRUBICIN dosage: unknown. During the same period patient was treated with DOCETAXEL, ENOXAPARIN, AUGMENTIN, DEXAMETHASONE, CITALOPRAM HYDROBROMIDE. Patient died on 03/10/2007.

Physician from GERMANY reported EPIRUBICIN problem on Aug 31, 2007. Male patient was diagnosed with hepatic neoplasm malignant and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, hypertensive crisis. EPIRUBICIN dosage: DAILY DOSE:50MG. Patient was hospitalized. Patient recovered.

EPIRUBICIN problem was reported by a Pharmacist from GERMANY on Aug 31, 2007. Male patient was diagnosed with hepatic neoplasm malignant and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: hypertensive crisis, nausea. EPIRUBICIN dosage: DAILY DOSE:40MG. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported EPIRUBICIN problem on Sept 11, 2007. Male patient, weighting 220.0 lb, was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood magnesium decreased, blood potassium decreased, blood pressure decreased, dizziness, dyspnoea, syncope. EPIRUBICIN dosage: 80 MG. Patient was hospitalized. Patient recovered.

EPIRUBICIN problem was reported by a Physician from GREECE on Sept 14, 2007. Female patient was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, sepsis. EPIRUBICIN dosage: DAILY DOSE:187MG. During the same period patient was treated with EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, METHOTREXATE. Patient died on 09/03/2007.

Health Professional from UNITED STATES reported EPIRUBICIN problem on Sept 26, 2007. Female patient, 38 years of age, weighting 149.0 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, jugular vein thrombosis, staphylococcal infection, subclavian vein thrombosis. EPIRUBICIN dosage: 149MG IV Q3WK. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Showing 1-75 of 130 Next >

Ask Our Patient Community about EPIRUBICIN

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol
Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol
Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

 F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
HaloperidolThis drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant
Insulin Glulisine recombinant
Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
LinezolidThis drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant
Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus
PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

 Q
Quazepam
Quetiapine
QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase (prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline
RazadyneThis drug has as active FDA Safety Alert (galantamine)
Rebetol (ribavirin)
ReclastThis drug has as active FDA Safety Alert (zoledronic acid)
Refludan (lepirudin recombinant)
Relenza (zanamivir)
RelpaxThis drug has as active FDA Safety Alert (eletriptan)
RemeronThis drug has as active FDA Safety Alert (mirtazapine)
Renagel (sevelamer)
Rescula (unoprostone isopropyl)
Restoril (temazepam)
Revatio (sildenafil)
Revlimid (lenalidomide)
Reyataz (atazanavir sulfate)
Ribasphere (ribavarin ribasphere)
Ribavarin ribasphere
Rifapentine
Rifaximin
RisedronateThis drug has as active FDA Safety Alert
Risperdal (risperidone)
Risperidone
Ritalin (methylphenidate)
Ritonavir
RituxanThis drug has as active FDA Safety Alert